Autologous iPSC-derived Retinal Pigment Epithelium Cell Therapy to Restore Vision in Blinding Eye Disease

Return to Grants

Grant Award Details

Grant Type:

Clinical Trial Stage Projects

Grant Number:

CLIN2-19416

Investigator(s):

Name:

Steven Schwartz

Institution:

Cellio Therapeutics

Type:

PI

Disease Focus:

Age-related macular degeneration, Vision Loss

Human Stem Cell Use:

Cell Line Generation:

Award Value:

$8,000,000

Status:

Active

Grant Application Details

Application Title:

Autologous iPSC-derived Retinal Pigment Epithelium Cell Therapy to Restore Vision in Blinding Eye Disease